QYTClass II
Over-The-Counter Covid-19 Antigen Test
21 CFR 866.3984 / Microbiology
QYT is the FDA product code for Over-The-Counter Covid-19 Antigen Test, a class II device type, regulated under 21 CFR 866.3984. FDA's definition for this code reads: "For the rapid, qualitative detection of SARS-CoV-2 virus nucleocapsid protein antigen in individuals 2 years and older". As of , FDA records hold 14 510(k) clearances under this code, the most recent dated , and 3 recalls.
Classification record
- Product code
- QYT
- Device name
- Over-The-Counter Covid-19 Antigen Test
- FDA definition
- For the rapid, qualitative detection of SARS-CoV-2 virus nucleocapsid protein antigen in individuals 2 years and older.
- Regulation
- 21 CFR 866.3984
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 14
- Ingested recalls
- 3
Clearances, product code QYT
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 3 |
Applicants with the most clearances
Product code QYT| Applicant | Clearances |
|---|---|
| Acon Laboratories, Inc. | 2 |
| Abbott Diagnostics Scarborough, Inc. | 1 |
| Access Bio, Inc. | 1 |
| Assure Tech LLC | 1 |
| CorDx, Inc. | 1 |
| Genabio Diagnostics Inc | 1 |
| Genbody.Inc. | 1 |
| Guangzhou Wondfo Biotech Co., Ltd. | 1 |
| Healgen Scientific LLC | 1 |
| iHealth Labs, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
